Date: 19 Dec 2012

MicroRNAs in Human Cancer

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Mature microRNAs (miRNAs) are single-stranded RNA molecules of 20–23-nucleotide (nt) length that control gene expression in many cellular processes. These molecules typically reduce the translation and stability of mRNAs, including those of genes that mediate processes in tumorigenesis, such as inflammation, cell cycle regulation, stress response, differentiation, apoptosis, and invasion. miRNA targeting is initiated through specific base-pairing interactions between the 5′ end (“seed” region) of the miRNA and sites within coding and untranslated regions (UTRs) of mRNAs; target sites in the 3′ UTR lead to more effective mRNA destabilization. Since miRNAs frequently target hundreds of mRNAs, miRNA regulatory pathways are complex. To provide a critical overview of miRNA dysregulation in cancer, we first discuss the methods currently available for studying the role of miRNAs in cancer and then review miRNA genomic organization, biogenesis, and mechanism of target recognition, examining how these processes are altered in tumorigenesis. Given the critical role miRNAs play in tumorigenesis processes and their disease specific expression, they hold potential as therapeutic targets and novel biomarkers.

An erratum to this chapter is available at 10.1007/978-94-007-5590-1_17
T. T. is cofounder of and scientific advisor to Alnylam Pharmaceuticals and scientific advisor to Regulus Therapeutics.
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-94-007-5590-1_17